<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pharmacological therapies for management of opium withdrawal - Rahimi‐Movaghar, A - 2018 | Cochrane Library</title> <meta content="Pharmacological therapies for management of opium withdrawal - Rahimi‐Movaghar, A - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007522.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pharmacological therapies for management of opium withdrawal - Rahimi‐Movaghar, A - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007522.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007522.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Pharmacological therapies for management of opium withdrawal" name="citation_title"/> <meta content="Afarin Rahimi‐Movaghar" name="citation_author"/> <meta content="Tehran University of Medical Sciences" name="citation_author_institution"/> <meta content="rahimia@tums.ac.ir" name="citation_author_email"/> <meta content="Jaleh Gholami" name="citation_author"/> <meta content="Tehran University of Medical Sciences" name="citation_author_institution"/> <meta content="Laura Amato" name="citation_author"/> <meta content="Lazio Regional Health Service" name="citation_author_institution"/> <meta content="Leila Hoseinie" name="citation_author"/> <meta content="Tehran University of Medical Sciences" name="citation_author_institution"/> <meta content="Reza Yousefi‐Nooraie" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Masoumeh Amin‐Esmaeili" name="citation_author"/> <meta content="Tehran University of Medical Sciences" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD007522.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/06/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007522.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007522.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007522.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Amantadine [therapeutic use]; Amines [therapeutic use]; Baclofen [therapeutic use]; Buprenorphine [adverse effects, therapeutic use]; Clonidine [adverse effects, therapeutic use]; Cyclohexanecarboxylic Acids [therapeutic use]; Gabapentin; Methadone [therapeutic use]; Opioid‐Related Disorders [*drug therapy]; Opium [*adverse effects, therapeutic use]; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome [*drug therapy]; Tramadol [therapeutic use]; gamma‐Aminobutyric Acid [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007522.pub2&amp;doi=10.1002/14651858.CD007522.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="eLIOL3Be";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007522\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007522\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","ms","pl","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007522.pub2",title:"Pharmacological therapies for management of opium withdrawal",firstPublishedDate:"Jun 21, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Drugs and Alcohol Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007522.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007522.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007522.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007522.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007522.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007522.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007522.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007522.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007522.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007522.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5325 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007522.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-sec-0108"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-sec-0056"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-sec-0102"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/appendices#CD007522-sec-0113"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/table_n/CD007522StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/table_n/CD007522StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pharmacological therapies for management of opium withdrawal</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#CD007522-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Afarin Rahimi‐Movaghar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#CD007522-cr-0003">Jaleh Gholami</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#CD007522-cr-0004">Laura Amato</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#CD007522-cr-0005">Leila Hoseinie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#CD007522-cr-0006">Reza Yousefi‐Nooraie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information#CD007522-cr-0007">Masoumeh Amin‐Esmaeili</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information/en#CD007522-sec-0117">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 June 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007522.pub2">https://doi.org/10.1002/14651858.CD007522.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007522-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007522-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007522-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007522-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007522-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007522-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007522-abs-0001" lang="en"> <section id="CD007522-sec-0001"> <h3 class="title" id="CD007522-sec-0001">Background</h3> <p>Pharmacologic therapies for management of heroin withdrawal have been studied and reviewed widely. Opium dependence is generally associated with less severe dependence and milder withdrawal symptoms than heroin. The evidence on withdrawal management of heroin might therefore not be exactly applicable for opium. </p> </section> <section id="CD007522-sec-0002"> <h3 class="title" id="CD007522-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety of various pharmacologic therapies for the management of the acute phase of opium withdrawal. </p> </section> <section id="CD007522-sec-0003"> <h3 class="title" id="CD007522-sec-0003">Search methods</h3> <p>We searched the following sources up to September 2017: CENTRAL, MEDLINE, Embase, CINAHL, PsycINFO, regional and national databases (IMEMR, Iranmedex, and IranPsych), main electronic sources of ongoing trials, and reference lists of all relevant papers. In addition, we contacted known investigators to obtain missing data or incomplete trials. </p> </section> <section id="CD007522-sec-0004"> <h3 class="title" id="CD007522-sec-0004">Selection criteria</h3> <p>Controlled clinical trials and randomised controlled trials on pharmacological therapies, compared with no intervention, placebo, other pharmacologic treatments, different doses of the same drug, and psychosocial intervention, to manage acute withdrawal from opium in a maximum duration of 30 days. </p> </section> <section id="CD007522-sec-0005"> <h3 class="title" id="CD007522-sec-0005">Data collection and analysis</h3> <p>We used the standard methodological procedures expected by Cochrane.</p> </section> <section id="CD007522-sec-0006"> <h3 class="title" id="CD007522-sec-0006">Main results</h3> <p>We included 13 trials involving 1096 participants. No pooled analysis was possible. Studies were carried out in three countries, Iran, India, and Thailand, in outpatient and inpatient settings. The quality of the evidence was generally very low. </p> <p>When the mean of withdrawal symptoms was provided for several days, we mainly focused on day 3. The reason for this was that the highest severity of opium withdrawal is in the second to fourth day. </p> <p>Comparing different pharmacological treatments with each other, clonidine was twice as good as methadone for completion of treatment (risk ratio (RR) 2.01, 95% confidence interval (CI) 1.69 to 2.38; 361 participants, 1 study, low‐quality evidence). All the other results showed no differences between the considered drugs: baclofen versus clonidine (RR 1.06, 95% CI 0.63 to 1.80; 66 participants, 1 study, very low‐quality evidence); clonidine versus clonidine plus amantadine (RR 1.03, 95% CI 0.86 to 1.24; 69 participants, 1 study); clonidine versus buprenorphine in an inpatient setting (RR 1.04, 95% CI 0.90 to 1.20; 1 study, 35 participants, very low‐quality evidence); methadone versus tramadol (RR 0.95, 95% CI 0.65 to 1.37; 1 study, 72 participants, very low‐quality evidence); methadone versus methadone plus gabapentin (RR 1.17, 95% CI 0.96 to 1.43; 1 study, 40 participants, low‐quality evidence), and tincture of opium versus methadone (1 study, 74 participants, low‐quality evidence). </p> <p>Comparing different pharmacological treatments with each other, adding amantadine to clonidine decreased withdrawal scores rated at day 3 (mean difference (MD) ‐3.56, 95% CI ‐5.97 to ‐1.15; 1 study, 60 participants, very low‐quality evidence). Comparing clonidine with buprenorphine in an inpatient setting, we found no difference in withdrawal symptoms rated by a physician (MD ‐1.40, 95% CI ‐2.93 to 0.13; 1 study, 34 participants, very low‐quality evidence), and results in favour of buprenorpine when rated by participants (MD ‐11.80, 95% CI ‐15.56 to ‐8.04). Buprenorphine was superior to clonidine in controlling severe withdrawal symptoms in an outpatient setting (RR 0.35, 95% CI 0.19 to 0.64; 1 study, 76 participants). We found no difference in the comparison of methadone versus tramadol (MD 0.04, 95% CI ‐2.68 to 2.76; 1 study, 72 participants) and in the comparison of methadone versus methadone plus gabapentin (MD ‐2.20, 95% CI ‐6.72 to 2.32; 1 study, 40 participants). </p> <p>Comparing clonidine versus buprenorphine in an outpatient setting, more adverse effects were reported in the clonidine group (1 study, 76 participants). Higher numbers of participants in the clonidine group experienced hypotension at days 5 to 8, headache at days 1 to 8, sedation at days 5 to 8, dizziness and dry mouth at days 1 to 10, and nausea at days 1 to 9. Sweating was reported in a significantly higher number of participants in the buprenorphine group at days 1 to 10. We found no difference between groups for all the other comparisons considering this outcome. </p> <p>Comparing different dosages of the same pharmacological detoxification treatment, a high dose of clonidine (1 to 1.2 mg/day) did not differ from a low dose of clonidine (0.5 to 0.6 mg/day) in completion of treatment in an inpatient setting (RR 1.00, 95% CI 0.84 to 1.19; 1 study, 68 participants), however a higher number of participants with hypotension was reported in the high‐dose group (RR 3.25, 95% CI 1.77 to 5.98). Gradual reduction of methadone was associated with more adverse effects than abrupt withdrawal of methadone (RR 2.25, 95% CI 1.02 to 4.94; 1 study, 20 participants, very low‐quality evidence). </p> </section> <section id="CD007522-sec-0007"> <h3 class="title" id="CD007522-sec-0007">Authors' conclusions</h3> <p>Results did not support using any specific pharmacological approach for the management of opium withdrawal due to generally very low‐quality evidence and small or no differences between treatments. However, it seems that opium withdrawal symptoms are significant, especially at days 2 to 4 after discontinuation of opium. All of the assessed medications might be useful in alleviating symptoms. Those who receive clonidine might experience hypotension. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007522-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007522-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007522-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007522-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007522-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007522-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD007522-abs-0009">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007522-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007522-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007522-abs-0005" lang="en"> <h3>Medications for the management of opium withdrawal</h3> <p><b>What was the aim of this review?</b> </p> <p>The aim of this Cochrane Review was to find out which medications are more effective and safer for the management of opium withdrawal. We collected and analysed all relevant studies to answer this question, and found 13 studies involving 1096 participants. </p> <p><b>Key messages</b> </p> <p>This review included the following 12 comparisons: baclofen versus clonidine, clonidine versus clonidine plus amantadine, clonidine versus buprenorphine, high‐dose clonidine versus low‐dose clonidine versus symptomatic management, clonidine versus methadone, methadone versus tramadol, methadone versus methadone plus gabapentin, gradual reduction of methadone versus sudden withdrawal of methadone, methadone plus amitriptyline versus methadone, diphenoxylate versus propoxyphene, three different protocols of tincture of opium, and tincture of opium versus methadone. The studies were carried out in three countries, Iran, India, and Thailand. Support from a pharmaceutical company in the form of free provision of medications was reported in only one study. </p> <p>The evidence is unclear as to whether any of the evaluated medications is more effective than another in the management of opium withdrawal. However, it seems that opium withdrawal symptoms are significant in the first days after discontinuation of opium. All of the assessed medications might be useful in alleviating symptoms. Use of clonidine might result in low blood pressure. </p> <p><b>What was studied in this review?</b> </p> <p>Withdrawal symptoms from opium are similar to those of other opioids such as heroin, but with mild intensity. Patients usually need medications to help alleviate withdrawal symptoms. </p> <p><b>What are the main results of the review?</b> </p> <p>We are uncertain as to whether the effects of clonidine differ from those of baclofen in number of participants who completed treatment (certainty of evidence was very low). </p> <p>We are uncertain as to whether adding amantadine to clonidine decreases the severity of withdrawal symptoms in days 1 to 3 in an inpatient setting, or whether it has an effect on completion of treatment (certainty of evidence was very low). </p> <p>We are uncertain as to whether buprenorphine is better than clonidine in controlling withdrawal symptoms in both inpatient and outpatient settings (certainty of evidence was very low). Adverse effects, including hypotension, were reported in higher numbers in the clonidine group. </p> <p>We are uncertain as to whether a high dose of clonidine differs from a low dose of clonidine in completion of treatment in an inpatient setting (certainty of evidence was very low), however a higher number of cases of low blood pressure was reported with high‐dose clonidine. </p> <p>Clonidine may be better than methadone in keeping patients in treatment in an outpatient setting. </p> <p>We are uncertain as to whether tramadol differs from methadone in completion of treatment and in alleviating withdrawal symptoms, and whether adverse effects are common with methadone (certainty of evidence was very low). </p> <p>Adding gabapentin to methadone may make little or no difference in completion of treatment and the severity of withdrawal symptoms. </p> <p>We are uncertain as to whether abrupt withdrawal of methadone is associated with fewer patient complaints than gradual reduction of methadone (certainty of evidence was very low). </p> <p>Tincture of opium may make no difference in completion of treatment, severity of withdrawal symptoms, and adverse effects in comparison to methadone. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>We searched for studies published up to September 2017.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007522-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007522-sec-0108">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007522-sec-0158">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007522-sec-0108"></div> <h3 class="title" id="CD007522-sec-0109">Implications for practice</h3> <section id="CD007522-sec-0109"> <p>Due to generally very low‐quality evidence and small or no differences between treatments, we could make no definitive conclusions regarding the use of any specific pharmacological approach for the management of opium withdrawal. However, it seems that opium withdrawal symptoms are significant, especially at days 2 to 4 after discontinuation of opium, and patients need pharmacologic assistance for passing through the detoxification process. </p> <p>The trials included in this study were carried out in a variety of inpatient and outpatient settings. Completion of treatment in the inpatient settings was generally high. However, this benefit should be weighed with the expenses of inpatient management. Withdrawal management is safe and can be provided in outpatient settings as well. However, since withdrawal management does not equate with treatment of dependence, long‐term care is necessary to prevent a return to opium use. </p> </section> <h3 class="title" id="CD007522-sec-0110">Implications for research</h3> <section id="CD007522-sec-0110"> <p>This review showed that little is known about the withdrawal management of opium with specific medications. There is a need for well‐designed, well‐reported studies assessing alpha2 adrenergic agonists, buprenorphine, methadone, and tincture of opium. More specifically, further studies comparing clonidine with buprenorphine might be helpful in determining the effectiveness of these medications on detoxification from opium. Since withdrawal from opium is less severe than from heroin, many patients might be effectively managed in outpatient settings with less cost. Carrying out trials in outpatient settings will therefore increase the utilisation of the results in general practice. </p> <p>Most of the included studies had serious risks of biases. Future studies should apply appropriate randomisation methods with adequate allocation concealment. For all dropped‐out cases, the reasons and time of dropping out, as well as the group to which each case belonged, should be provided. The number of participants who have been assessed in each arm should be provided for all measures. It is recommended that published and well‐studied questionnaires or checklists be used for the assessment of withdrawal symptoms and that a total score in predetermined times for each person be calculated and the mean withdrawal score for those in each intervention arm be provided. Providing the scores in addition to graphs will increase the utility of data in future reviews. The most frequently assessed days in the studies are days 3, 5, and 7, and providing data for these days will allow comparisons of results between studies. Peak withdrawal score is also a good measure that makes it possible to compare interventions with different durations. Carrying out urine tests for opium is recommended as an appropriate outcome measure for assessing successful completion of withdrawal management. Adverse effects should also be reported specifically for each intervention arm to allow for a safety comparison. It is also recommended that in studies in which individuals with dependence to a variety of opioids are included, the results be provided separately for each type of opioid. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007522-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007522-sec-0029"></div> <div class="table" id="CD007522-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> management of opium withdrawal<br/> <b>Setting:</b> outpatient and inpatient<br/> <b>Intervention:</b> pharmacological detoxification treatment<br/> <b>Comparison:</b> other pharmacological detoxification treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with other pharmacological detoxification treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with pharmacological detoxification treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment:</p> <p>baclofen versus clonidine</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.06<br/> (0.63 to 1.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>66<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>441 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>468 per 1000<br/> (278 to 794) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: clonidine versus clonidine plus amantadine, inpatient setting</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.86 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>69<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>857 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>883 per 1000<br/> (737 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: clonidine versus buprenorphine, inpatient setting</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.04<br/> (0.90 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>35<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>952 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>990 per 1000<br/> (857 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: clonidine versus methadone</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.01<br/> (1.69 to 2.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>361<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>415 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>834 per 1000<br/> (701 to 988) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: methadone versus tramadol</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.65 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>72<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>629 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>597 per 1000<br/> (409 to 861) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: methadone versus methadone plus gabapentin</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/> (0.96 to 1.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>850 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>994 per 1000<br/> (816 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: tincture of opium versus methadone</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.95 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>74<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/> (950 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of bias: high risk of selection, performance, and detection bias; unclear risk of attrition bias.<br/> <sup>2</sup>Downgraded two levels for imprecision: one study with very few participants.<br/> <sup>3</sup>Downgraded one level for risk of bias: high risk of performance and detection bias; unclear risk of selection bias.<br/> <sup>4</sup>Downgraded one level for risk of bias: high risk of reporting bias; unclear risk of selection bias.<br/> <sup>5</sup>Downgraded one level for risk of bias: high risk of performance, detection, attrition, and reporting bias; unclear risk of selection bias.<br/> <sup>6</sup>Downgraded one level for risk of bias: high risk of reporting bias; unclear risk of selection and attrition bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007522-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> management of opium withdrawal<br/> <b>Setting:</b> outpatient and inpatient<br/> <b>Intervention:</b> pharmacological detoxification treatment<br/> <b>Comparison:</b> other pharmacological detoxification treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with other pharmacological detoxification treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with pharmacological detoxification treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal symptoms at day 3: clonidine versus clonidine plus amantadine, inpatient setting </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean withdrawal symptoms at day 3: clonidine versus clonidine plus amantadine was 9.83 days. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.56 days lower<br/> (5.97 lower to 1.15 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal symptoms at day 3: clonidine versus buprenorphine,inpatient setting</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean withdrawal symptoms at day 3: clonidine versus buprenorphine in inpatient setting was 12.5 days. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.4 days lower<br/> (2.93 lower to 0.13 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal symptoms at day 3: methadone versus tramadol</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean withdrawal symptoms at day 3: methadone versus tramadol was 8.5 days.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.04 days higher<br/> (2.68 lower to 2.76 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal symptoms at day 3: methadone versus methadone plus gabapentin</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean withdrawal symptoms at day 3: methadone versus methadone plus gabapentin was 13.4 days. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.2 days lower<br/> (6.72 lower to 2.32 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of bias: high risk of performance and detection bias; unclear risk of selection bias.<br/> <sup>2</sup>Downgraded two levels for imprecision: one study with very few participants.<br/> <sup>3</sup>Downgraded one level for risk of bias: high risk of reporting bias; unclear risk of selection bias.<br/> <sup>4</sup>Downgraded one level for risk of bias: high risk of reporting bias; unclear risk of selection and attrition bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007522-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007522-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007522-sec-0126">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD007522-sec-0030"></div> <section id="CD007522-sec-0031"> <h3 class="title" id="CD007522-sec-0031">Description of the condition</h3> <p>Opioid dependence is a major health and social issue in most societies, but access and cultural attitudes affect the patterns of opioid use among different countries. Opium is used for pleasure, as a painkiller, a hypnotic, and for the treatment of premature ejaculation (<a href="./references#CD007522-bbs2-0129" title="AhmadiJ , Babaee‐BeigiM , AlishahiM , MaanyI , HidariT . Twelve‐month maintenance treatment of opium‐dependent patients. Journal of Substance Abuse Treatment2004;26(1):363‐6. ">Ahmadi 2004</a>). In opium‐cultivating countries and some of their neighbours, opium use is more common than use of other opioids. This is particularly true in Afghanistan, Laos, Myanmar, and Iran (<a href="./references#CD007522-bbs2-0157" title="United Nations Office on Drugs and Crime. World Drug Report 2011. Vienna: United Nations Publications, 2011. ">UNODC 2011</a>). Opium has traditionally been used in Pakistan, India, China, Thailand, Bangladesh, Nepal, Sri Lanka, Turkey, Iraq, Jordan, Egypt, Bahrain, Oman, and Kuwait, as well (<a href="./references#CD007522-bbs2-0151" title="RayR , KattimaniS , SharmaHK . Opium abuse and its management: global scenario. Department of Mental Health and Substance Abuse Management, World Health Organization, AND National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India, 2006. ">Ray 2006</a>; <a href="./references#CD007522-bbs2-0159" title="World Health Organization, Regional Office for the Eastern Mediterranean. A draft of the 5‐year regional strategic planning on substance abuse, 2005‐2009. 2004. ">WHO/EMRO 2004</a>). In some of these countries, such as in Iran, opium has always been the most widely abused illicit drug. A national survey on epidemiology of drug use in Iran showed that among the adult male population, 8.9% and 3% were current opium users and opium dependents, respectively (<a href="./references#CD007522-bbs2-0143" title="IranianMoH . Epidemiologic study of drug abuse in Iran. Tehran. Iranian Ministry of Health2002. ">Iranian MoH 2002</a>). A new national household survey from Iran also showed that opium is the main substance that leads to substance use disorders (<a href="./references#CD007522-bbs2-0131" title="Amin‐EsmaeiliM , Rahimi‐MovagharA , SharifiV , HajebiA , RadgoodarziR , MojtabaiR , et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization, results from the Iranian mental health survey. Addiction2016;111:1836‐47. [DOI: 10.1111/add.13453] ">Amin‐Esmaeili 2016</a>). A systematic review on drug use in Iranian universities reported that the prevalence of opium use ranged from 7.1% to 10.2%, and that the daily use ranged from 3.4% to 8.8% among  male students. The rates were much lower in female students (<a href="./references#CD007522-bbs2-0147" title="Rahimi‐MovagharA , IzadianE , YunesianM . Drug use situation in university students in Iran: a literature review. Payesh [Health Monitor]2006;5:83‐104. ">Rahimi‐Movaghar 2006</a>). Another new systematic review reported opium abuse to be 4% in college and high school students (<a href="./references#CD007522-bbs2-0145" title="MenatiW , ValizadehR , MenatiR , NiaziM , NazarzadehM , BidelZ . Determination of opium abuse prevalence in Iranian young people: a systematic review and meta‐analysis. Journal of Substance Use2017;22:3‐10. ">Menati 2016</a>). A drug use survey in Afghanistan in 2005 reported the existence of about 150,000 regular opium users (0.6% of the total population) in that country (<a href="./references#CD007522-bbs2-0128" title="Afghanistan Ministry of Counter Narcotics &amp; United Nations Office on Drugs and Crime. Afghanistan drug use survey 2005: Executive summary. 2005. ">Afghanistan Counter Narcotics &amp; UNODC 2005</a>); in four years, this number increased to 230,000 (<a href="./references#CD007522-bbs2-0156" title="United Nations Office on Drugs and Crime. Drug use in Afghanistan 2009 survey: executive summary. www.unodc.org/documents/data‐and‐analysis/Studies/Afghan‐Drug‐Survey‐2009‐Executive‐Summary‐web.pdf (accessed prior to 25 May 2018). ">UNODC 2010</a>). In India, the National Household Survey on Drug Abuse in 2002 reported that 0.5% of adult males were current (use within last month) opium users, and that there were about 1.4 million opium users in that country (<a href="./references#CD007522-bbs2-0150" title="RayR . The extent, pattern and trends of drug abuse in India: national survey. India. Ministry of Social Justice and Empowerment, United Nations Office on Drugs and Crime. Regional Office for South Asia, 2004. ">Ray 2004</a>). Another household survey in the state of Arunachal Pradesh in India showed that 6.6% of individuals aged 15 years or older were current opium users (<a href="./references#CD007522-bbs2-0133" title="ChaturvediHK , MahantaJ , BajpaiRC , PandeyA . Correlates of opium use: retrospective analysis of a survey of tribal communities in Arunachal Pradesh, India. BMC Public Health2013;13:325. ">Chaturvedi 2013</a>). In many countries, the pattern of drug use has shifted from softer opioids to harder ones like heroin in the last decade; however, there are at least 5 million regular opium users in the world. </p> <p>Opium is obtained from the unripe seed capsules of the poppy plant, <i>Papaver somniferum</i>. The milky juice is dried and powdered to make powdered opium, which contains a number of alkaloids. These alkaloids can be divided into two distinct chemical classes, phenanthrenes and benzylisoquinolines. The principal phenanthrenes are morphine (10% of opium), codeine (0.5%), and thebaine (0.2%). The principal benzylisoquinolines are papaverine (1%) and noscapine (6%) (<a href="./references#CD007522-bbs2-0132" title="BruntonLL , LazoJS , ParkerKL . Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th Edition. New York (NY): McGraw‐Hill, 2006. ">Brunton 2006</a>).   </p> <p>Opium has the properties of opioid analgesics. Its analgesic and sedative actions are due mainly to its content of morphine. However, opium acts less rapidly than morphine, since opium appears to be more slowly absorbed. The relaxing action of the papaverine and noscapine on intestinal muscle makes it more constipating than morphine. Alkaloids of opium have their own mechanisms of action. Papaverine has a direct relaxant effect on smooth muscle and causes gastrointestinal disturbance. Noscapine is a centrally acting cough suppressant. Codeine is also used for cough suppression (<a href="./references#CD007522-bbs2-0155" title="SweetmanS . In: SeanC Sweetman BPharm FRPharmS editor(s). Martindale: The Complete Drug Reference. London: Pharmaceutical Press, 2007. [ISBN 0‐85369‐687‐X] ">Sweetman 2007</a>). Thebaine acts like strychnine, and may produce convulsions (<a href="./references#CD007522-bbs2-0146" title="PubChem . Thebaine. PubChem Substance and Compound databases2008. [PubChem Identifier: SID 134971785URL: https://pubchem.ncbi.nlm.nih.gov/substance/134971785] ">PubChem 2008</a>; <a href="./references#CD007522-bbs2-0161" title="YamazoeY , NumataH , YanagitaT . Thebaine metabolites in the urine of rhesus monkeys. Japanese Journal of Pharmacology1981;31(3):433‐42. ">Yamazoe 1981</a>). </p> <p>Diamorphine hydrochloride (heroin) is an acetylated morphine derivative and is a more potent opioid analgesic than morphine. Diamorphine is much more lipid‐soluble and has a more rapid onset and shorter duration of action than morphine. Although deacetylation to morphine occurs rapidly in the blood, it occurs only slowly in the cerebral spinal fluid following intraspinal injection of diamorphine (<a href="./references#CD007522-bbs2-0155" title="SweetmanS . In: SeanC Sweetman BPharm FRPharmS editor(s). Martindale: The Complete Drug Reference. London: Pharmaceutical Press, 2007. [ISBN 0‐85369‐687‐X] ">Sweetman 2007</a>). </p> <p>Currently, opium continues to be consumed by traditional means, that is eating and smoking. Although in most cases opium is used occasionally and mainly in male gatherings, regular use of opium occurs and causes dependence (<a href="./references#CD007522-bbs2-0151" title="RayR , KattimaniS , SharmaHK . Opium abuse and its management: global scenario. Department of Mental Health and Substance Abuse Management, World Health Organization, AND National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India, 2006. ">Ray 2006</a>). Opium dependence is less debilitating than heroin dependence. Opium users have a more stable lifestyle than heroin users. A high proportion of opium users are married and live with their families (<a href="./references#CD007522-bbs2-0144" title="JafariS , Rahimi‐MovagharA , CraibKJP , BaharlouS , MathiasR . A follow‐up study of drug users in Southern Iran. Addiction Research &amp; Theory2010;18(1):59‐70. ">Jafari 2010</a>; <a href="./references#CD007522-bbs2-0152" title="RazaghiEM , Rahimi‐MovagharA , HosseiniM , MohammadK , MadaniS . Rapid situation assessment of drug abuse in Iran. Tehran: Iranian Welfare Organization &amp; United Nations International Drug Control Program (UNDCP), 1999:18. ">Razaghi 1999</a>). Psychiatric comorbidity is significantly less in opium users than in heroin users (<a href="./references#CD007522-bbs2-0134" title="GhaffarnejadA , ZiaadiniH , BanazadehN . Comparative evaluation of psychiatric disorders in opium and heroin dependent patients. Addiction and Health2009;1(1):20‐4. ">Ghaffarnejad 2009</a>). Opium dependence is not a benign disorder; however, in comparison to heroin, opium costs less, requires fewer doses per day, and has a less toxic withdrawal (<a href="./references#CD007522-bbs2-0158" title="WestermeyerJ , PengG . Opium and heroin addicts in Laos. II. A study of matched pairs. Journal of Nervous and Mental Disease1977;164(5):351‐4. ">Westermeyer 1977</a>). </p> <p>Cessation of opium use in an individual who is opium dependent gives rise to a classical opiate withdrawal syndrome of mild intensity. The signs and symptoms of the syndrome include irritability, anxiety, apprehension, muscular and abdominal pains, chills, nausea, diarrhoea, yawning, lacrimation, sweating, sneezing, rhinorrhoea, general weakness, and insomnia. The acute physical signs of withdrawal syndrome usually stop after 14 days, but, as happens for heroin dependence, protracted syndrome that includes reduced well‐being, malaise, and periodic strong cravings may continue for months. Completion of withdrawal and remaining abstinent is difficult for most opium dependents. Although relapse rate after completion of withdrawal is high, withdrawal remains a required first step for many forms of longer‐term treatment (<a href="./references#CD007522-bbs2-0160" title="World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: World Health Organization, 2009. ">World Health Organization 2009</a>). As opium is a less abusive and less harmful substance than heroin, and individuals with opium dependence generally have a higher socioeconomic status and less degree of psychopathology, in practice many of those with opium dependence are provided withdrawal management when referred for treatment. </p> </section> <section id="CD007522-sec-0032"> <h3 class="title" id="CD007522-sec-0032">Description of the intervention</h3> <p>Limited information is currently available on the management of opium withdrawal. Several pharmacological modalities of detoxification including alpha2 adrenergic agonists, buprenorphine, reducing dose of methadone, opioid antagonists (with minimal sedation or under heavy sedation), and symptomatic medication, with or without psychosocial treatment, have been used for opiate dependence, most of them focused on heroin users (<a href="./references#CD007522-bbs2-0130" title="AmatoL , DavoliM , FerriM , AliR . Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD003409.pub4] ">Amato 2013</a>; <a href="./references#CD007522-bbs2-0135" title="GowingL , AliR , WhiteJM . Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002025.pub4] ">Gowing 2009a</a>; <a href="./references#CD007522-bbs2-0136" title="GowingL , AliR , WhiteJM . Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002021.pub3] ">Gowing 2009b</a>; <a href="./references#CD007522-bbs2-0137" title="GowingL , AliR , WhiteJM . Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD002022.pub3] ">Gowing 2010</a>; <a href="./references#CD007522-bbs2-0138" title="GowingL , FarrellM , AliR , WhiteJM . Alpha2‐adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD002024.pub4] ">Gowing 2014</a>). </p> </section> <section id="CD007522-sec-0033"> <h3 class="title" id="CD007522-sec-0033">Why it is important to do this review</h3> <p>There are no clear guidelines on how to treat individuals dependent on opium (<a href="./references#CD007522-bbs2-0162" title="ZarghamiM . Is methadone substitution the best treatment of choice for opioid dependence?. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(2):1‐4. ">Zarghami 2008</a>). All guidelines for management of opioid dependence are based on evidence for managing heroin‐dependent patients, which constitute the main population of opioid dependents in Western countries. However, people dependent on opium appear to differ in several ways from those who use heroin. Opium has different pharmacokinetics, adverse effects, and severity of withdrawal. In addition, modes of administration of opium and socio‐demographic characteristics of users are also different from heroin. Consequently, managing opium dependence based on evidence on management of heroin dependence is the subject of debate. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007522-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007522-sec-0034">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007522-sec-0130">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007522-sec-0034"></div> <p>To assess the effectiveness and safety of various pharmacological therapies for the management of the acute phase of opium withdrawal. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007522-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007522-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007522-sec-0131">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007522-sec-0035"></div> <section id="CD007522-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007522-sec-0037"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials and controlled clinical trials on pharmacological detoxification treatments to manage acute withdrawal from opium. The trials should have provided detailed information on the type and dose of pharmacological therapies, and have listed at least one major outcome measure. </p> </section> <section id="CD007522-sec-0038"> <h4 class="title">Types of participants</h4> <p>Opium‐dependent individuals who underwent acute withdrawal management.</p> <p>Trials including participants with additional physical or psychological illness were also eligible, and there was no restriction on setting. </p> </section> <section id="CD007522-sec-0039"> <h4 class="title">Types of interventions</h4> <section id="CD007522-sec-0040"> <h5 class="title">Experimental intervention</h5> <p>Pharmacological detoxification treatments, including alpha2 adrenergic agonists, buprenorphine taper, methadone taper, opioid antagonists with minimal sedation, opioid antagonists under heavy sedation, taper of tincture of opium, and other pharmacologic treatments. </p> </section> <section id="CD007522-sec-0041"> <h5 class="title">Control or comparison interventions</h5> <p> <ul id="CD007522-list-0001"> <li> <p>Placebo</p> </li> <li> <p>No intervention</p> </li> <li> <p>Other pharmacological interventions alone or in combination with any psychosocial intervention </p> </li> <li> <p>Different dosages of the same drug for management of acute opium withdrawal</p> </li> <li> <p>Any psychosocial intervention</p> </li> </ul> </p> <p>We excluded studies comparing the same pharmacologic treatment administered in different settings. We also excluded studies comparing different protocols for anaesthesia in ultrarapid opioid detoxification. </p> </section> </section> <section id="CD007522-sec-0042"> <h4 class="title">Types of outcome measures</h4> <section id="CD007522-sec-0043"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007522-list-0002"> <li> <p>Completion of treatment, as number of participants completing the detoxification programme</p> </li> <li> <p>Use of opium at the end of the detoxification programme, as number of participants with positive urinalysis or number of participants having gone through naloxone challenge test or who have started naltrexone </p> </li> <li> <p>Duration and severity of signs and symptoms of withdrawal, including patient self rating </p> </li> <li> <p>Nature, incidence, and course of adverse effects</p> </li> <li> <p>Mortality rate</p> </li> </ol> </p> <p>We differentiated withdrawal signs and symptoms from adverse effects of treatment exactly as defined in each included study. </p> <p>When the mean of withdrawal symptoms was provided for several days, we presented all results in the analysis section, and mainly focused on day 3 in the text. The reason for this is that opium withdrawal is most severe in the second to fourth day. </p> </section> <section id="CD007522-sec-0044"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007522-list-0003"> <li> <p>Client satisfaction</p> </li> <li> <p>Use of other abusive substances</p> </li> <li> <p>Fatal or non‐fatal overdose rate</p> </li> <li> <p>Relapse rate at follow‐up</p> </li> </ol> </p> </section> </section> </section> <section id="CD007522-sec-0045"> <h3 class="title">Search methods for identification of studies</h3> <p>We undertook both electronic and manual searches to identify eligible studies. There was no language restriction. </p> <section id="CD007522-sec-0046"> <h4 class="title">Electronic searches</h4> <p>We searched the following international bibliographic databases:</p> <p> <ul id="CD007522-list-0004"> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 9) in the Cochrane Library; </p> </li> <li> <p>MEDLINE via Ovid (1966 to 13 September 2017);</p> </li> <li> <p>Embase via Embase.com (1974 to 13 September 2017);</p> </li> <li> <p>CINAHL (Cumulative Index to Nursing and Allied Health Literature) via EBSCOhost (1982 to 11 September 2017); </p> </li> <li> <p>PsycINFO via Ovid (1887 to 11 September 2017).</p> </li> </ul> </p> <p>We also searched the following regional and national bibliographic databases:</p> <p> <ul id="CD007522-list-0005"> <li> <p>IMEMR (Index Medicus for WHO Eastern Mediterranean) (1984 to 13 September 2017);</p> </li> <li> <p>Iranmedex (up to 13 September 2017);</p> </li> <li> <p>IranPsych (up to 17 March 2012; the database has not been updated since March 2012).</p> </li> </ul> </p> <p>We searched the following trials registries:</p> <p> <ul id="CD007522-list-0006"> <li> <p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>) (searched 13 September 2017); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>) (searched 13 September 2017); </p> </li> <li> <p>CenterWatch Clinical Trials Listing Service (<a href="http://www.centerwatch.com/" target="_blank">www.centerwatch.com</a>) (searched 22 September 2017); </p> </li> <li> <p>ISRCTN registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com</a>) (searched 13 September 2017). </p> </li> </ul> </p> </section> <section id="CD007522-sec-0047"> <h4 class="title">Searching other resources</h4> <p>We also searched conference proceedings likely to contain trials relevant to the review and the reference lists of all relevant papers to identify further studies. </p> <p>We contacted the authors of retrieved studies for missing data or incomplete trials. The full search strategies for all databases, as well as the numbers of retrieved records, are included in <a href="./appendices#CD007522-sec-0114">Appendix 1</a>. </p> </section> </section> <section id="CD007522-sec-0048"> <h3 class="title" id="CD007522-sec-0048">Data collection and analysis</h3> <section id="CD007522-sec-0049"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MAE, JG) inspected the reports identified by the search by reading titles and abstracts. Any disagreements were resolved through discussion with third review author (ARM). We obtained the full texts of those studies deemed potentially relevant, and two review authors (ARM, JG) assessed these for inclusion in the review. Any disagreements were resolved by discussion. The process of study selection, including the numbers of retrieved and selected documents, is presented in the flowchart according to a modified PRISMA statement (<a href="#CD007522-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD007522-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007522-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD007522-sec-0050"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (MAE, JG) independently extracted data using a data extraction form. Any disagreements were resolved through discussion with a third review author (ARM). As the included studies assessed different comparisons, we did not perform meta‐analysis and summarised the key findings narratively. </p> <p>We intended to extract the following data if provided in each included study.</p> <p> <ul id="CD007522-list-0007"> <li> <p>Study characteristics:</p> <ul id="CD007522-list-0008"> <li> <p>Author and year of publication</p> </li> <li> <p>City and country</p> </li> <li> <p>Study implementation year</p> </li> <li> <p>Funding</p> </li> </ul> </li> <li> <p>Methods:</p> <ul id="CD007522-list-0009"> <li> <p>Study design</p> </li> <li> <p>Setting and sites</p> </li> <li> <p>Number of arms (groups)</p> </li> <li> <p>Sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants/therapists/assessors</p> </li> <li> <p>Comparability of participants in all arms</p> </li> <li> <p>Intention‐to‐treat analysis</p> </li> <li> <p>Instruments administered to assess study outcomes</p> </li> <li> <p>The person who assessed study outcomes</p> </li> </ul> </li> <li> <p>Participants:</p> <ul id="CD007522-list-0010"> <li> <p>Eligibility criteria</p> </li> <li> <p>Number of participants in each arm at baseline</p> </li> <li> <p>Sex</p> </li> <li> <p>Age (range, mean and standard deviation)</p> </li> <li> <p>Comorbidities</p> </li> <li> <p>Other drugs used</p> </li> </ul> </li> <li> <p>Interventions:</p> <ul id="CD007522-list-0011"> <li> <p>Main pharmacologic interventions in each arm</p> </li> <li> <p>Details of pharmacologic interventions (dose, frequency, duration)</p> </li> <li> <p>Other interventions</p> </li> <li> <p>Adherence</p> </li> </ul> </li> <li> <p>Outcomes:</p> <ul id="CD007522-list-0012"> <li> <p>Number who completed treatment</p> </li> <li> <p>Negative urinalysis for morphine at the end of detoxification programme</p> </li> <li> <p>Severity of withdrawal (mean withdrawal score or number of participants who complained of each withdrawal symptom) in different days of detoxification process </p> </li> <li> <p>Severity of craving (mean craving score)</p> </li> <li> <p>Drug adverse effects</p> </li> <li> <p>Client satisfaction</p> </li> <li> <p>Use of other abusive substances</p> </li> <li> <p>Mortality rate</p> </li> <li> <p>Fatal and non‐fatal overdose rate</p> </li> <li> <p>Negative urinalysis for morphine in follow‐up</p> </li> </ul> </li> </ul> </p> </section> <section id="CD007522-sec-0051"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (JG, ARM) independently assessed the risk of bias of the included studies using the criteria recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007522-bbs2-0142" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). Any disagreements were resolved by discussion The recommended approach for assessing risk of bias in studies included in a Cochrane Review is a two‐part tool, addressing seven specific domains, namely sequence generation and allocation concealment (selection bias), blinding of participants and providers (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias), and other sources of bias. The first part of the tool involves describing what was reported to have occurred in the study. The second part of the tool involves assigning a judgement relating to the risk of bias for that entry, in terms of low, high or unclear risk. We used the criteria indicated by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> adapted to the addiction field to make these judgements. See <a href="./appendices#CD007522-sec-0115">Appendix 2</a> for details. </p> <p>The domains of sequence generation and allocation concealment (avoidance of selection bias) were addressed in the tool by a single entry for each study. </p> <p>We considered blinding of participants, personnel, and outcome assessment (avoidance of performance bias and detection bias) separately for objective outcomes (e.g. dropout) and subjective outcomes (e.g. duration and severity of signs and symptoms of withdrawal, adverse effects). </p> <p>We considered incomplete outcome data (avoidance of attrition bias) for all outcomes except for drop out from treatment, which is frequently the primary outcome measure in trials on addiction. </p> </section> <section id="CD007522-sec-0052"> <h4 class="title">Measures of treatment effect</h4> <p>We presented dichotomous outcomes (e.g. number of participants who completed treatment) as risk ratios (RR). We presented continuous outcomes (e.g. severity of withdrawal) as mean differences (MD). We expressed uncertainties in the results with 95% confidence intervals (CI). </p> <p>When the mean of withdrawal symptoms was provided for several days, we presented all results in the analysis section, and mainly focused on day 3 in the text. The reason for this is that withdrawal from opium is most severe in the second to fourth day. </p> </section> <section id="CD007522-sec-0053"> <h4 class="title">Data synthesis</h4> <p>Where possible, we had planned to combine the outcomes from the individual trials through meta‐analysis (comparability of intervention and outcomes between trials) using a random‐effects model, as we expected a certain degree of heterogeneity among trials. However, meta‐analysis was not possible due to substantial differences between interventions in the studies. We reported results of the included studies individually for each trial, re‐expressed as RR for dichotomous outcomes and MD for continuous outcomes with 95% CI. We presented the results using Review Manager 5 (<a href="./references#CD007522-bbs2-0153" title="The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD007522-sec-0054"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We would have assessed statistical heterogeneity using the I<sup>2</sup> statistic and the Chi<sup>2</sup> test (x2) (<a href="./references#CD007522-bbs2-0142" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). In addition, we intended to consider factors such as setting and duration of treatment as confounders, taking these into account in the analysis wherever possible. However, we did not perform sensitivity analysis due to heterogeneity among interventions and comparisons. </p> <section id="CD007522-sec-0055"> <h5 class="title">'Summary of findings' table</h5> <p>We assessed the overall quality of the evidence for the primary outcome using the GRADE system (<a href="./references#CD007522-bbs2-0139" title="OxmanAD , GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(19):1490‐4. ">GRADE 2004</a>; <a href="./references#CD007522-bbs2-0140" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7560):924‐6. ">Guyatt 2008</a>; <a href="./references#CD007522-bbs2-0141" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. ">Guyatt 2011</a>; <a href="./references#CD007522-bbs2-0154" title="SchünemannHJ , JaeschkeR , CookD , BriaW , El‐SolhA , ErnstA , et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. American Journal of Respiratory and Critical Care Medicine2006;174(5):605‐14. ">Schünemann 2006</a>), which takes into account issues not only related to internal validity but also to external validity, such as directness of results. The 'Summary of findings' tables present the main findings of a review in a transparent and simple tabular format. In particular, they provide key information concerning the quality of evidence, the magnitude of effect of the interventions examined, and the sum of available data on the main outcomes. </p> <p>The GRADE system uses the following criteria for assigning grades of evidence.</p> <p> <ul id="CD007522-list-0013"> <li> <p>High: We are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>Grading is decreased for the following reasons.</p> <p> <ul id="CD007522-list-0014"> <li> <p>Serious (‐1) or very serious (‐2) study limitation for risk of bias.</p> </li> <li> <p>Serious (‐1) or very serious (‐2) inconsistency between study results.</p> </li> <li> <p>Some (‐1) or major (‐2) uncertainty about directness (the correspondence between the population, the intervention, or the outcomes measured in the studies actually found and those under consideration in our systematic review). </p> </li> <li> <p>Serious (‐1) or very serious (‐2) imprecision of the pooled estimate.</p> </li> <li> <p>Strong suspicion of publication bias (‐1).</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007522-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007522-sec-0056"></div> <section id="CD007522-sec-0057"> <h3 class="title">Description of studies</h3> <section id="CD007522-sec-0058"> <h4 class="title">Results of the search</h4> <p>The search identified 1624 records through international bibliographic databases, 1919 through regional and national bibliographic databases, 90 through electronic sources of ongoing trials, and 216 through other sources. Five hundred and nine out of 1624 studies identified from the international databases were duplicates and were removed. In total, we screened 3340 records and excluded 3212 after our review of titles and abstracts for inclusion criteria. From the remaining 128 records, we excluded 108 studies (109 articles) after our review of the full texts. Another five studies are awaiting classification due to unavailability of the full text or inability to contact authors to inquire about the types of opioids used by participants. Finally, 13 clinical trials (from 14 articles) were considered to be eligible for the review and were included. The flow diagram of steps of the searches and the results is presented in <a href="#CD007522-fig-0001">Figure 1</a>. </p> </section> <section id="CD007522-sec-0059"> <h4 class="title">Included studies</h4> <p>The 13 included studies involved 1096 participants. Only two studies were randomised controlled trials (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>); the other studies were evaluated as controlled clinical trials. See <a href="./references#CD007522-sec-0123" title="">Characteristics of included studies</a>. </p> <section id="CD007522-sec-0060"> <h5 class="title">Interventions</h5> <p>The included studies considered 12 different comparisons.</p> <p> <ol id="CD007522-list-0015"> <li> <p>Baclofen versus clonidine (1 study, 66 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Ahmadi-Abhari-2003" target="_blank">Ahmadi Abhari 2003</a>). </p> </li> <li> <p>Clonidine versus clonidine plus amantadine (1 study, 69 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Amiri-2014" target="_blank">Amiri 2014</a>). </p> </li> <li> <p>Clonidine versus buprenorphine (2 studies, 111 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Salehi-2007a" target="_blank">Salehi 2007a</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Ziaaddini-2012" target="_blank">Ziaaddini 2012</a>). </p> </li> <li> <p>High‐dose clonidine versus low‐dose clonidine versus symptomatic management (1 study, 102 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Satija-1988" target="_blank">Satija 1988</a>). </p> </li> <li> <p>Clonidine versus methadone (1 study, 361 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Taraghi-2005" target="_blank">Taraghi 2005</a>). </p> </li> <li> <p>Methadone versus tramadol (1 study reported in 2 papers, 72 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Salehi-2007b" target="_blank">Salehi 2007b</a>). </p> </li> <li> <p>Methadone versus methadone plus gabapentin (1 study, 40 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Kheirabadi-2008" target="_blank">Kheirabadi 2008</a>). </p> </li> <li> <p>Gradual reduction of methadone versus sudden withdrawal (1 study, 20 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Lal-1976" target="_blank">Lal 1976</a>). </p> </li> <li> <p>Methadone plus amitriptyline versus methadone (1 study, 44 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Salehi-2005" target="_blank">Salehi 2005</a>). </p> </li> <li> <p>Diphenoxylate versus propoxyphene (1 study, 105 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Singh-1984" target="_blank">Singh 1984</a>). </p> </li> <li> <p>Three different protocols of tincture of opium (1 study, 32 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Somogyi-2008" target="_blank">Somogyi 2008</a>). </p> </li> <li> <p>Tincture of opium versus methadone (1 study, 74 participants) (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Tabassomi-2016" target="_blank">Tabassomi 2016</a>). </p> </li> </ol> </p> <p>Clonidine and methadone were used in six trials, and buprenorphine and tincture of opium in two trials. Maximum doses of clonidine were 0.2 to 1.2 mg/day, and maximum doses of methadone were 10 to 65 mg/day. Baclofen, tramadol, amitriptyline, gabapentin, diphenoxylate, and propoxyphene were used in one trial each. Three studies assessed different dosage or tapering mechanism for a medication, namely for clonidine, methadone, and tincture of opium. </p> <p>One study had three arms (<a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>), comparing high‐dose clonidine versus low‐dose clonidine versus symptomatic treatment; we analysed the comparison between the first two arms. Another study claimed to have four arms (<a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>), however it actually consisted of two trials in different time frames: diphenoxylate and propoxyphene were compared in one study in high doses and in another study in low doses. The remaining 11 studies had two arms. </p> <p>In 12 studies, all participants were opium dependent. In one study with 66 participants (<a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#STD-Ahmadi-Abhari-2003" target="_blank">Ahmadi Abhari 2003</a>), 90% were opium dependent; however, separate data for the opium dependents were not available. We decided to include the study and use the data for the all 66 participants. </p> <p>For a more detailed description of studies, see <a href="https://archie.cochrane.org/sections/documents/view?version=z1803261657376353328708886651813%26format=REVMAN#CHARACTERISTICS_OF_INCLUDED_STUDIES" target="_blank">Characteristics of included studies</a>. </p> </section> <section id="CD007522-sec-0061"> <h5 class="title">Participants</h5> <p>The studies included 1096 participants, of whom only 14 (from 4 studies) were female. One study did not report the gender of the participants (<a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>). Age range was from 18 to 70 years. One study only reported that participants were required to be under 40 (<a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>). The mean age of the total samples ranged from 25.5, in <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>, to 41, in <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>. Five studies provided the average amount of daily opium use in participants, which ranged from 4.8, in <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a> and <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>, to 78, in <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>. One study required that participants use less than 2 g of opium per day (<a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>). </p> </section> <section id="CD007522-sec-0062"> <h5 class="title">Settings and duration of trials</h5> <p>Six and five trials used outpatient and inpatient settings, respectively. Two studies did not report the setting used. The duration of detoxification programmes was 3 to 15 days in inpatient settings and 3 to 25 days in outpatient settings. The 13 studies were carried out in three countries: Iran (nine studies), India (three studies), and Thailand (one study). Six studies did not report the enrolment dates. The other studies reported enrolment dates from 1980 to 2013. Ten studies were published after 2002, and three other studies (from India) were published before 1989. </p> </section> <section id="CD007522-sec-0063"> <h5 class="title">Outcomes</h5> <p>The included studies reported the following outcomes.</p> <p> <ol id="CD007522-list-0016"> <li> <p>Number of participants completing treatment (8 studies).</p> </li> <li> <p>Withdrawal scores (13 studies), using a variety of scales. The total mean withdrawal scores were provided in six studies. </p> </li> <li> <p>Adverse effects (8 studies).</p> </li> <li> <p>Mortality rate (3 studies).</p> </li> </ol> </p> <p>The included studies used the following measures for assessing withdrawal signs and symptoms. </p> <p> <ol id="CD007522-list-0017"> <li> <p>Short Opioid Withdrawal Scale, 10‐item, subjective measure (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>). </p> </li> <li> <p>Clinical Opioid Withdrawal Scale (COWS), 11 symptoms, include both subjective and objective measures (<a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). </p> </li> <li> <p>Subjective Opiate Withdrawal Scale, 16‐item (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>). </p> </li> <li> <p>Methadone Symptoms Checklist, 16‐item, subjective measure (<a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>). </p> </li> <li> <p>Withdrawal Symptoms Rating Scale, 24‐item, objective measure (<a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>). </p> </li> <li> <p>Adjective Rating Withdrawal Scale (ARWS), 16‐item, subjective measure (<a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). </p> </li> <li> <p>Mental symptoms checklist, 5‐item, subjective measure (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>). </p> </li> <li> <p>Objective Opioid Withdrawal Scale (OOWS), 13‐item, objective measure (<a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>). </p> </li> </ol> </p> </section> <section id="CD007522-sec-0064"> <h5 class="title">Types of comparisons</h5> <p>We grouped the studies into two main comparisons.</p> <p> <ol id="CD007522-list-0018"> <li> <p>Pharmacological detoxification treatments versus other pharmacological detoxification interventions. </p> </li> <li> <p>Pharmacological detoxification treatments versus different dosages of the same drug.</p> </li> </ol> </p> <p>Within the two comparisons, we compared each type of pharmacological intervention.</p> </section> </section> <section id="CD007522-sec-0065"> <h4 class="title">Excluded studies</h4> <p>We excluded a total of 108 studies (from 109 articles). Some studies had more than one reason for exclusion. Reasons for exclusion were as follows. </p> <p> <ul id="CD007522-list-0019"> <li> <p>Participants not dependent on opium (85 studies).</p> </li> <li> <p>Types of opioids were not reported (3 studies).</p> </li> <li> <p>Not a controlled trial (18 studies).</p> </li> <li> <p>Anaesthesia procedures (5 studies).</p> </li> <li> <p>Not on the management of withdrawal symptoms within the first 30 days after stoppage of opium use (5 studies). </p> </li> <li> <p>Same pharmacologic interventions were provided in all arms (3 studies).</p> </li> <li> <p>No results on outcome measures provided (1 study).</p> </li> <li> <p>Participants were not dependent on opioids (1 study).</p> </li> <li> <p>Opium users were included, however despite contacting the authors, we were unable to obtain separate data for opium users (6 studies). </p> </li> </ul> </p> </section> </section> <section id="CD007522-sec-0066"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD007522-fig-0002">Figure 2</a> and <a href="#CD007522-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD007522-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007522-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD007522-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007522-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD007522-sec-0067"> <h4 class="title">Allocation</h4> <section id="CD007522-sec-0068"> <h5 class="title">Random sequence generation</h5> <p>Of the 13 included studies, only two reported a random sequence generation method and were considered as at low risk of bias (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>). We judged six studies as being at unclear risk of bias because they did not provide sufficient information about method of sequence generation (<a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>; <a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). We judged five studies as being at high risk of bias (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>; <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>; <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>): <a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a> and <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a> used alternate assignment; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a> reported assignment based on the order of presentation; and <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a> reported allocation depending on participants’ self reported prior opium use. </p> </section> <section id="CD007522-sec-0069"> <h5 class="title">Allocation concealment</h5> <p>Of the 13 included studies, only two reported allocation concealment and were considered as at low risk of bias (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>). We judged six studies as being at unclear risk of bias because they did not provide sufficient information about allocation concealment method (<a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>; <a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). We judged five studies in which allocation concealment was not done as being at high risk of bias (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>; <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>; <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>). </p> </section> </section> <section id="CD007522-sec-0070"> <h4 class="title">Blinding</h4> <section id="CD007522-sec-0071"> <h5 class="title">Performance bias for objective outcomes</h5> <p>Seven studies provided detailed information about blinding of participants and personnel and were considered as at low risk of bias for this domain (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a> did not assess any objective outcomes. We judged the remaining five studies as at high risk of bias: four studies were not blinded (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>), and <a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a> stated that the drugs were given in identical capsules and that participants and the evaluating doctor were blinded, but we judged that blinding was impossible because of symptomatic therapy in one of the study groups. </p> </section> <section id="CD007522-sec-0072"> <h5 class="title">Performance bias for subjective outcomes</h5> <p>Seven studies provided detailed information about blinding of participants and personnel and were considered as at low risk of bias for this domain (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). We judged the remaining six studies to be at high risk of bias: four studies were not blinded (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>); <a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a> stated that the drugs were given in identical capsules and that participants and the evaluating doctor were blinded, but we judged that blinding was impossible because of symptomatic therapy in one of the study groups; and in <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a> blinding of participants was done for the type of medication but not for the dose of medications. </p> </section> <section id="CD007522-sec-0073"> <h5 class="title">Detection bias for objective outcomes</h5> <p>Six studies provided detailed information about blinding of outcome assessors and were considered as being at low risk of bias for this domain (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a> did not assess any objective outcomes. In four studies, either blinding of outcome assessment was not done (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>), or the provided information was insufficient (<a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>); however, for assessment of the main objective outcome (completion of treatment), it is unlikely that the assessment was affected by lack of blinding of the assessors. In the two remaining studies (<a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>; <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>), blinding of outcome assessment was not done, and vital signs were assessed as objective outcomes, therefore we considered these two studies to be at high risk of detection bias. </p> </section> <section id="CD007522-sec-0074"> <h5 class="title">Detection bias for subjective outcomes</h5> <p>Six studies provided detailed information about blinding of outcome assessors and were considered as being at low risk of bias for this domain (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). We judged <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a> as at unclear risk of bias because they did not provide sufficient information on blinding of outcome assessment. In six studies blinding of outcome assessors was not done (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>; <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>; <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>), therefore assessment of subjective outcomes, such as subjective withdrawal symptoms and adverse effects, was prone to high risk of bias. </p> </section> </section> <section id="CD007522-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>We considered incomplete outcome data for all outcomes except completion of treatment (or dropout). Of the 13 studies, we judged six as being at low risk of attrition bias (<a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>; <a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). In <a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>, the two study groups were reported to have nearly equal non‐compliance and loss to follow‐up cases (i.e. 5 out of 35 (14.3%) in the clonidine group versus 4 of 34 (11.8%) in the clonidine plus amantadine group). <a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a> reported 3 of 20 excluded participants (15%) in the placebo group and none in the gabapentin group, which is unlikely to result in biased estimates. <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a> and <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a> had no missing data. <a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a> reported that an equal number of participants dropped out in the three groups (4 of 34 in each group (11.8%)); <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a> reported that only 1 of 21 participants (4.8%) in the clonidine group and none of 14 participants in the buprenorphine group discontinued treatment. There was insufficient information in three studies (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>), which we considered as at unclear risk of bias. We judged the remaining four studies to be at high risk of bias (<a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>; <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>; <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>). <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a> reported 13 dropouts from a total of 89 participants (14.6%), of which 4 were due to hypotension (group not reported), and 7 in the clonidine group versus 2 in the buprenorphine group were due to losses to follow‐up and may have induced bias in effect estimates. <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a> reported 15 dropouts of 105 participants (14.3%), and <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a> reported 13 dropouts of 45 participants (28.9%), but their groups were not reported. <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a> reported 20 dropouts of 120 participants (16.7%) in the clonidine group and 141 dropouts of 241 participants (58.5%) in the methadone group, but some key outcomes like adverse effects were reported only in those who completed treatment. </p> </section> <section id="CD007522-sec-0076"> <h4 class="title">Selective reporting</h4> <p>In eight studies (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>; <a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>; <a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>; <a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>; <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>; <a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>; <a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>), the outcomes presented in the results section were consistent with those specified in the methods section. <a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a> was registered in the Iranian Clinical Trials Registry, and the presented outcomes were consistent with the registered protocol. We considered five studies as being at high risk of reporting bias (<a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>; <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>; <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>; <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>; <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). <a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a> did not report completion rate of treatment in the 25 days, and mean of total withdrawal score at days 7, 15, 17, and 25. <a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>, <a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>, and <a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a> did not report completion rate. In <a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>, the rate of positive urinary samples for opioids at the end of six months was reported as one of the main outcomes of the study, but the results are not presented, and there is no report about side effects. </p> <p>In addition, there were reporting errors in two studies (<a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>; <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>). In <a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>, the difference between the two groups in mean mental score at day 15 is reported as significant, but as obtained from the results tables it is insignificant. There are several reporting errors in <a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>: for example, the rates presented for patient satisfaction in each group are not matched with the reported significance of difference (P value). </p> <p>Six studies did not report source of funding. In the remaining studies, academic institutions were mainly reported as the source of funding. Only one study mentioned funding from a pharmaceutical company (<a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>), for which two companies had provided the two compared medications. </p> </section> </section> <section id="CD007522-sec-0077"> <h3 class="title" id="CD007522-sec-0077">Effects of interventions</h3> <p>See: <a href="./full#CD007522-tbl-0001"><b>Summary of findings for the main comparison</b> Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</a>; <a href="./full#CD007522-tbl-0002"><b>Summary of findings 2</b> Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</a> </p> <p>As the included trials investigated outcomes of different comparisons, it was not possible to perform meta‐analysis. </p> <section id="CD007522-sec-0078"> <h4 class="title">Primary outcomes</h4> <section id="CD007522-sec-0079"> <h5 class="title">Comparison 1: Pharmacological detoxification treatments versus other pharmacological detoxification interventions </h5> <section id="CD007522-sec-0080"> <h6 class="title">1.1 Completion of treatment</h6> <p>See <a href="./full#CD007522-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD007522-sec-0081"> <p><b>1.1.1 Baclofen versus clonidine</b></p> <p>One study involving 66 participants found no difference between groups (risk ratio (RR) 1.06, 95% confidence interval (CI) 0.63 to 1.80; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>). </p> </section> <section id="CD007522-sec-0082"> <p><b>1.1.2 Clonidine versus clonidine plus amantadine</b></p> <p>One study involving 69 participants found no difference between groups (RR 1.03, 95% CI 0.86 to 1.24; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>). </p> </section> <section id="CD007522-sec-0083"> <p><b>1.1.3 Clonidine versus buprenorphine in an inpatient setting</b></p> <p>One study involving 35 participants found no difference between groups (RR 1.04, 95% CI 0.90 to 1.20; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). </p> </section> <section id="CD007522-sec-0084"> <p><b>1.1.4 Clonidine versus methadone</b></p> <p>One study involving 361 participants found that people taking clonidine were twice as likely to complete treatment as those taking methadone (RR 2.01, 95% CI 1.69 to 2.38; low‐quality evidence) (<a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>). </p> </section> <section id="CD007522-sec-0085"> <p><b>1.1.5 Methadone versus tramadol</b></p> <p>One study involving 72 participants found no difference between groups (RR 0.95, 95% CI 0.65 to 1.37; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>). </p> </section> <section id="CD007522-sec-0086"> <p><b>1.1.6 Methadone versus methadone plus gabapentin</b></p> <p>One study involving 40 participants found no difference between groups (RR 1.17, 95% CI 0.96 to 1.43; low‐quality evidence) (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>). </p> </section> <section id="CD007522-sec-0087"> <p><b>1.1.7 Tincture of opium versus methadone</b></p> <p>One study involving 74 participants found that all participants completed treatment in both groups (RR 1.00, 95% CI 0.95 to 1.05; low‐quality evidence) (<a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>). </p> <p>For all see <a href="./references#CD007522-fig-0004" title="">Analysis 1.1</a>. </p> </section> </section> <section id="CD007522-sec-0088"> <h6 class="title">1.2 Duration and severity of signs and symptoms of withdrawal at day 3 of treatment</h6> <p>See <a href="./full#CD007522-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD007522-sec-0089"> <p><b>1.2.1 Clonidine versus clonidine plus amantadine</b></p> <p>One study involving 60 participants found that adding amantadine to clonidine decreased withdrawal scores rated at day 3 (mean difference (MD) ‐3.56, 95% CI ‐5.97 to ‐1.15; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0002" title="AmiriS , MalekA , TofighniaF , AslBH , SeidyA . Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial. Iranian Journal of Psychiatry2014;9(3):142‐6. ">Amiri 2014</a>). </p> </section> <section id="CD007522-sec-0090"> <p><b>1.2.2 Clonidine versus buprenorphine in an inpatient setting</b></p> <p>One study involving 34 participants found no difference between groups using the Clinical Opiate Withdrawal Scale at day 3, rated by a psychiatrist (MD ‐1.40, 95% CI ‐2.93 to 0.13). Furthermore, this study found results in favour of buprenorphine using the Adjective Rating Withdrawal Scale at day 3, rated by participants (MD ‐11.80, 95% CI ‐15.56 to ‐8.04; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). </p> <p>1.2.3. Clonidine versus buprenorphine in an outpatient setting</p> <p>One study involving 76 participants found that a smaller number of participants experienced severe withdrawal symptoms in the buprenorphine group at day 3 (RR 0.35, 95% 0.19 to 0.64; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>). </p> </section> <section id="CD007522-sec-0091"> <p><b>1.2.4 Methadone versus tramadol</b></p> <p>One study involving 72 participants found no difference between groups using mean withdrawal score at day 3 (MD 0.04, 95% CI ‐2.68 to 2.76). In addition, the difference in mean mental withdrawal score at day 3 did not differ between groups (MD ‐0.23, 95% CI ‐2.10 to 1.64; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>). </p> </section> <section id="CD007522-sec-0092"> <p><b>1.2.5 Methadone versus methadone plus gabapentin</b></p> <p>One study involving 40 participants found no difference between groups at day 3 (MD ‐2.20, 95% CI ‐6.72 to 2.32; low‐quality evidence) (<a href="./references#CD007522-bbs2-0003" title='*KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients. Addiction2008;103(9):1495‐9. KheirabadiGR , RanjkeshM , MaracyMR , SalehiM . "Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients": Corrigendum. Addiction2009;104(10):1776. '>Kheirabadi 2008</a>). </p> <p>For all see <a href="./references#CD007522-fig-0005" title="">Analysis 1.2</a>. </p> <p>Comparing baclofen versus clonidine, one study involving 66 participants found no difference between groups at days 0, 1, 2, 3, 4, 7, and 14 (results provided only by graphs) (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>). </p> <p>Comparing clonidine versus methadone, one study involving 361 participants assessed the severity of 10 withdrawal symptoms and found that dysphoria, agitation, irritability, muscle aches, yawning, and hot flashes were more severe in the clonidine group (<a href="./references#CD007522-bbs2-0012" title="TaraghiSh , Pour AfkariN , SeidiA . A comparative study of effectiveness of two methods of detoxification in opium dependent patients. Medical Journal of Tabriz University of Medical Sciences &amp; Health Services2005;27(3):41‐6. ">Taraghi 2005</a>). However, the time and number of assessments were not reported. </p> <p>Comparing methadone plus amitriptyline versus methadone, one study involving 44 opium participants found no difference between groups in mean withdrawal score; lower mental withdrawal scores at days 7 and 25 in the amitriptyline group, but not at days 15 and 17; and lower scores on the McGill Pain Questionnaire at days 15, 17, and 25 in the amitriptyline group, but not at day 7 (<a href="./references#CD007522-bbs2-0005" title="SalehiM , Mir KhalafA , BarekatainM . Amitriptyline efficacy in control of acute opioid withdrawal syndrome. Koomesh, Journal of Semnan University of Medical Sciences2005;6(3):195‐200. ">Salehi 2005</a>). </p> <p>One study with 105 participants involved four groups: low‐dose diphenoxylate, low‐dose propoxyphene, high‐dose diphenoxylate, and high‐dose propoxyphene (<a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>). Comparing low doses of diphenoxylate and propoxyphene, insomnia and diarrhoea were significantly lower in the diphenoxylate group. The study found no differences between these groups with regard to other withdrawal symptoms. Comparing high doses of diphenoxylate and propoxyphene, the study found no difference in the number of participants with each of eight withdrawal symptoms. Although there was no randomisation process between low and high dose of each medication, the authors concluded that symptoms were lower in the high‐dose regimen than in the low‐dose regimen. </p> </section> </section> <section id="CD007522-sec-0093"> <h6 class="title">Use of opium at the end of detoxification programme: number of participants with positive urinalysis, or number of participants to have gone through naloxone challenge test or to have started naltrexone </h6> <p>Only one study involving 35 participants, comparing clonidine versus buprenorphine in an inpatient setting, reported data on participants staying in naltrexone treatment at 6 months, showing no difference between groups (RR 1.50, 95% CI 0.80 to 2.82) (<a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). </p> </section> <section id="CD007522-sec-0094"> <h6 class="title">Adverse effects</h6> <p>Comparing baclofen versus clonidine, one study involving 66 participants assessed severity of adverse effects at days 0, 1, 2, 3, 4, 7, and 14, and showed no difference between groups (only graphs were provided) (<a href="./references#CD007522-bbs2-0001" title="Ahmadi AbhariSA , ShabaniA , AkhundzadehSh , AsadiSM . Baclofen and clonidine in opioid detoxification. Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)2003;8(31):26‐35. ">Ahmadi Abhari 2003</a>). Only two adverse effects, euphoria (46.7% in the baclofen group versus 0% in the clonidine group, P &lt; 0.01) and vomiting (33% in the baclofen group versus 0% in the clonidine group, P &lt; 0.05) were significantly more frequent in the baclofen group. </p> <p>Comparing clonidine versus buprenorphine in an outpatient setting, one study involving 76 participants reported that 4 participants dropped out due to hypotension, but it is not specified to which group they were allocated, and these four cases have been removed from analysis (<a href="./references#CD007522-bbs2-0006" title="SalehiB , JafariniaN , GheblehF , MansoriA . A comparative study on opium withdrawal of buprenorphine and clonidine. Journal of Qazvin University of Medical Sciences2007;11(3):57‐65. ">Salehi 2007a</a>). In the 76 participants that remained in treatment, hypotension, headache, sedation, dizziness, dry mouth, nausea, constipation, and sweating were assessed and reported every day from day 1 to day 10. More adverse effects were reported in the clonidine group. Significantly higher numbers of participants in the clonidine group experienced hypotension at days 5 to 8, headache at days 1 to 8, sedation at days 5 to 8, dizziness and dry mouth at days 1 to 10, and nausea at days 1 to 9. Sweating was reported in a significantly higher number of participants in the buprenorphine group at days 1 to 10. </p> <p>Comparing clonidine versus buprenorphine in an inpatient setting, one study involving 35 participants did not report adverse effects (<a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>), stating only that one participant in the clonidine group left the study before completion, on the second day due to blood pressure below 90/60 mmHg. </p> <p>Comparing methadone versus tramadol, one study involving 72 participants reported no difference between groups for side effect scores on day 7 (<a href="./references#CD007522-bbs2-0007" title="SalehiM , AmanatkarM , BarekatainM . Comparison of the efficacy of methadone and tramadol in opioid‐assisted detoxification. Iranian Journal of Medical Sciences2007;33(1):28‐31. SalehiM , AmanatkarM , BarekatainM . Tramadol versus methadone for the management of acute opioid withdrawal: an add‐on study. Journal of Research in Medical Sciences2006;11(3):185‐9. ">Salehi 2007b</a>). On day 14, participants in the methadone group had significantly more drowsiness (P = 0.0195) and sweating (P = 0.003) than those in tramadol group (very low‐quality evidence). </p> <p>Comparing tincture of opium versus methadone, one study involving 74 participants found no difference between groups in the incidence of all nine adverse effects evaluated (headache, dizziness, sleepiness, misbalance, constipation, nausea, perspiration, tension, and respiratory depression) (<a href="./references#CD007522-bbs2-0011" title="TabassomiF , ZarghamiM , ShiranMR , FarniaS , DavoodiM . Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double‐blind, controlled trial. Journal of Addictive Diseases2016;35(1):8‐14. ">Tabassomi 2016</a>). </p> <p>Comparing diphenoxylate versus propoxyphene, one study involving 105 participants reported no adverse effects with low‐dose regimens (<a href="./references#CD007522-bbs2-0009" title="SinghG , Singh SachdevaJ , KumarA . A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts. Indian Journal of Psychiatry1984;26(4):343‐8. ">Singh 1984</a>); one participant on high‐dose diphenoxylate reported constipation, and two participants on high‐dose propoxyphene reported mild giddiness. </p> </section> <section id="CD007522-sec-0095"> <h6 class="title">Mortality rate</h6> <p>No deaths were reported in the included studies.</p> </section> </section> <section id="CD007522-sec-0096"> <h5 class="title">Comparison 2: Pharmacological detoxification treatments versus different dosages of the same drug </h5> <section id="CD007522-sec-0097"> <h6 class="title">Completion of treatment</h6> <p>Comparing high‐dose clonidine versus low‐dose clonidine, one study involving 68 participants found no difference between the two groups for completion of treatment (RR 1.00, 95% CI 0.84 to 1.19) (<a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>). </p> <p>Comparing gradual reduction of methadone versus sudden withdrawal of methadone, one study involving 20 participants reported that all participants were retained for 15 days in treatment, although completion of treatment was not reported as an outcome measure (<a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>). </p> </section> <section id="CD007522-sec-0098"> <h6 class="title">Withdrawal symptoms</h6> <p>Comparing gradual reduction of methadone versus sudden withdrawal of methadone, one study involving 20 participants reported that the number of participants complaining of withdrawal symptoms during treatment was higher in the "gradual reduction" group than in the "stable dose and sudden withdrawal" group (RR 2.25, 95% CI 1.02 to 4.94) (<a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>). The number of participants with body aches and pain, insomnia, rhinorrhoea, diarrhoea, nervousness and tremor was higher in the "gradual reduction" group. In addition, symptoms were reported to be more severe and tended to persist throughout the period of withdrawal in the "gradual reduction" group. </p> </section> <section id="CD007522-sec-0099"> <h6 class="title">Adverse effects</h6> <p>Comparing high‐dose clonidine versus low‐dose clonidine, one study involving 60 participants reported that more participants experienced hypotension in the high‐dose group (RR 3.25, 95% CI 1.77 to 5.98), however no definition was provided for hypotension and no participant required specific therapy to treat hypotension (<a href="./references#CD007522-bbs2-0008" title="SatijaDC , NataniGD , PurohitDR , GaurR , BhatiGS . A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication. Indian Journal of Psychiatry1988;30(1):55‐9. ">Satija 1988</a>). </p> <p>Gradual reduction of methadone was associated with more adverse effects than abrupt withdrawal of methadone (RR 2.25, 95% CI 1.02 to 4.94; 1 study, 20 participants, very low‐quality evidence), (<a href="./references#CD007522-bbs2-0004" title="LalB , SinghG . Experiences of a methadone detoxification programme for opium addicts. Drug and Alcohol Dependence1976;1(6):391‐8. ">Lal 1976</a>). </p> <p>Comparing three different protocols of tincture of opium, one study involving 45 participants reported no significant adverse effects in all three groups (<a href="./references#CD007522-bbs2-0010" title="SomogyiAA , LarsenM , AbadiRM , JittiwutikarnJ , AliR , WhiteJM . Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology2008;66(5):640‐7. ">Somogyi 2008</a>). </p> </section> <section id="CD007522-sec-0100"> <h6 class="title">Mortality rate</h6> <p>No deaths were reported in the included studies.</p> <p>No useful data were provided for all the other primary outcomes.</p> </section> </section> </section> <section id="CD007522-sec-0101"> <h4 class="title">Secondary outcomes</h4> <p>We intended to extract and present data for our secondary outcomes as well, however only one study, 35 participants, reported results at six‐month follow‐up, and showed no significant difference between groups (RR 1.50, 95% CI 0.80 to 2.82; very low‐quality evidence) (<a href="./references#CD007522-bbs2-0013" title="ZiaaddiniH , NasirianM , NakhaeeN . Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid‐dependents. Addiction &amp; Health2012;4(3‐4):79‐86. ">Ziaaddini 2012</a>). </p> <p>No other reliable data on the secondary outcomes were provided in the included studies.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007522-sec-0102" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007522-sec-0102">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007522-sec-0152">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007522-sec-0102"></div> <section id="CD007522-sec-0103"> <h3 class="title" id="CD007522-sec-0103">Summary of main results</h3> <p>Regular use of opium can lead to physical and psychological dependence. Opium dependence imposes a considerable burden on societies, being associated with decreased productivity, family problems, crime, and increased healthcare costs. It is important to use specific evidence for management of opium dependence and to understand to what degree the evidence for treatment of heroin dependence applies to opium dependence as well. </p> <p>In most Asian countries, detoxification is more accessible and affordable than maintenance treatment. Another review on maintenance treatment of opium was inconclusive regarding the effective maintenance management of opium dependence (<a href="./references#CD007522-bbs2-0148" title="Rahimi‐MovagharA , Amin‐EsmaeiliM , HefaziM , Yousefi‐NooraieR . Pharmacological therapies for maintenance treatments of opium dependence. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD007775.pub2] ">Rahimi‐Movaghar 2013</a>). </p> <p>We included 13 trials involving 1096 participants in this review. The 13 trials evaluated 12 different comparisons, and no pooled analysis was possible. Studies were carried out in three countries, Iran (nine studies), India (three studies), and Thailand (one study). Six studies were conducted in outpatient settings and five in inpatient settings. In two studies the setting was not described. The quality of the evidence was generally very low. </p> <p>In the five studies carried out in inpatient settings, the reported completion rate ranged from 86% to 100%. In the five studies carried out in outpatient settings and assessing this outcome, completion rate ranged from 41% to 100%. No case of mortality was reported in the 13 included studies (although most studies did not mention that there were no deaths). These results show an overall promise with withdrawal management of opium. </p> <p>In the single comparisons, we found low‐quality evidence that clonidine was better than methadone for number of participants completing treatment. We found no difference between groups for this outcome for any of the other comparisons. Regarding withdrawal symptoms, adding amantadine to clonidine decreased withdrawal scores at days 1 to 3, and buprenorphine was superior to clonidine in controlling severe withdrawal symptoms in the first week in an outpatient setting. We found no differences for all the other comparisons. </p> <p>Regarding adverse effects, more adverse effects were reported with clonidine when compared with buprenorphine in an outpatient setting, in particular a higher number of participants with hypotension was reported with high‐dose clonidine. </p> <p>No analysis was possible for three comparisons, since only graphs or P values were provided in the papers. These comparisons were diphenoxylate versus propoxyphene, three different protocols of opium tincture, and the addition of amitriptyline to methadone. </p> </section> <section id="CD007522-sec-0104"> <h3 class="title" id="CD007522-sec-0104">Overall completeness and applicability of evidence</h3> <p>We intended to answer the question regarding the most effective interventions for management of opium withdrawal. However, based on this review we were unable to answer this question. This review presented 12 different comparisons, the evidence for which was generally of very low quality. The included studies were carried out mainly in Iran, with a few in India and Thailand. Four of the 13 included studies were published in the Persian language. Specifically, Iran is a country with a high rate of opium use and a high number of publications on opioids (<a href="./references#CD007522-bbs2-0149" title="Rahimi‐MovagharA , Amin‐EsmaeiliM , SafarcheratiA , SaramiH , RafieyH . A scientometric study of Iranian scientific productions in the field of substance use and addiction research in the years 2008 to 2012. Addiction &amp; Health2015;7(3‐4):99‐108. ">Rahimi‐Movaghar 2015</a>). The included studies suffer for low internal validity. In terms of external validity, it should be noted that the included studies involved 1096 participants, who were from the part of the world with the highest prevalence of opium use and dependence. However, women were underepresented in the study population, and an inpatient setting was used in many of the studies, which in the actual world is not the case, as most opium dependents go through detoxification in outpatient settings. All studies assessed severity of withdrawal symptoms during treatment, but with different scales. Other main outcomes such as completion of treatment and adverse effects were not assessed in all studies. Other objective outcomes, such as urinalysis for morphine and naloxone challenge test at the end of detoxification, were rarely investigated. </p> </section> <section id="CD007522-sec-0105"> <h3 class="title" id="CD007522-sec-0105">Quality of the evidence</h3> <p>Our GRADE assessment of the quality of the evidence of the included studies was very low. The major flaws in the studies were risk of selection, performance, detection, attrition, and reporting bias. In addition, sample size was very small in all of the included studies, therefore the results were highly imprecise. </p> </section> <section id="CD007522-sec-0106"> <h3 class="title" id="CD007522-sec-0106">Potential biases in the review process</h3> <p>We contacted study authors to request unpublished data and were able to obtain significant data for this review. </p> </section> <section id="CD007522-sec-0107"> <h3 class="title" id="CD007522-sec-0107">Agreements and disagreements with other studies or reviews</h3> <p>Two previous systematic reviews assessed similar comparisons in opioid‐dependent individuals:</p> <p> <ol id="CD007522-list-0020"> <li> <p><a href="./references#CD007522-bbs2-0135" title="GowingL , AliR , WhiteJM . Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002025.pub4] ">Gowing 2009a</a> compared buprenorphine with clonidine for management of opioid withdrawal (10 studies) and found that buprenorphine was superior than clonidine in controlling withdrawal symptoms, which was similar to our findings. However, we included one study with very low‐quality evidence reporting no difference between groups in completion rate of opium dependents in an inpatient setting, which differed from the findings of <a href="./references#CD007522-bbs2-0135" title="GowingL , AliR , WhiteJM . Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002025.pub4] ">Gowing 2009a</a>; </p> </li> <li> <p><a href="./references#CD007522-bbs2-0138" title="GowingL , FarrellM , AliR , WhiteJM . Alpha2‐adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD002024.pub4] ">Gowing 2014</a> compared methadone and clonidine for management of opioid withdrawal (9 studies, 659 participants) and found no difference between groups in completion rate. However, we found low‐quality evidence from one study that completion rate in opium dependents was higher with clonidine than with tapering doses of methadone. </p> </li> </ol> </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007522-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/urn:x-wiley:14651858:media:CD007522:CD007522-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_t/tCD007522-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007522-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007522-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/urn:x-wiley:14651858:media:CD007522:CD007522-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_t/tCD007522-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007522-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007522-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/urn:x-wiley:14651858:media:CD007522:CD007522-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_t/tCD007522-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007522-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007522-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/urn:x-wiley:14651858:media:CD007522:CD007522-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_t/tCD007522-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pharmacological detoxification treatment versus other pharmacological detoxification treatment, Outcome 1 Completion of treatment." data-id="CD007522-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Pharmacological detoxification treatment versus other pharmacological detoxification treatment, Outcome 1 Completion of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/references#CD007522-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007522-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/urn:x-wiley:14651858:media:CD007522:CD007522-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_t/tCD007522-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Pharmacological detoxification treatment versus other pharmacological detoxification treatment, Outcome 2 Withdrawal symptoms at day 3." data-id="CD007522-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Pharmacological detoxification treatment versus other pharmacological detoxification treatment, Outcome 2 Withdrawal symptoms at day 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/references#CD007522-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/media/CDSR/CD007522/image_n/nCD007522-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007522-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> management of opium withdrawal<br/> <b>Setting:</b> outpatient and inpatient<br/> <b>Intervention:</b> pharmacological detoxification treatment<br/> <b>Comparison:</b> other pharmacological detoxification treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with other pharmacological detoxification treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with pharmacological detoxification treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment:</p> <p>baclofen versus clonidine</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.06<br/> (0.63 to 1.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>66<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>441 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>468 per 1000<br/> (278 to 794) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: clonidine versus clonidine plus amantadine, inpatient setting</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.86 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>69<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>857 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>883 per 1000<br/> (737 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: clonidine versus buprenorphine, inpatient setting</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.04<br/> (0.90 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>35<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>952 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>990 per 1000<br/> (857 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: clonidine versus methadone</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.01<br/> (1.69 to 2.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>361<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>415 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>834 per 1000<br/> (701 to 988) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: methadone versus tramadol</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.65 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>72<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>629 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>597 per 1000<br/> (409 to 861) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: methadone versus methadone plus gabapentin</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/> (0.96 to 1.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>850 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>994 per 1000<br/> (816 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Completion of treatment: tincture of opium versus methadone</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.95 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>74<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/> (950 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of bias: high risk of selection, performance, and detection bias; unclear risk of attrition bias.<br/> <sup>2</sup>Downgraded two levels for imprecision: one study with very few participants.<br/> <sup>3</sup>Downgraded one level for risk of bias: high risk of performance and detection bias; unclear risk of selection bias.<br/> <sup>4</sup>Downgraded one level for risk of bias: high risk of reporting bias; unclear risk of selection bias.<br/> <sup>5</sup>Downgraded one level for risk of bias: high risk of performance, detection, attrition, and reporting bias; unclear risk of selection bias.<br/> <sup>6</sup>Downgraded one level for risk of bias: high risk of reporting bias; unclear risk of selection and attrition bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007522-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> management of opium withdrawal<br/> <b>Setting:</b> outpatient and inpatient<br/> <b>Intervention:</b> pharmacological detoxification treatment<br/> <b>Comparison:</b> other pharmacological detoxification treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with other pharmacological detoxification treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with pharmacological detoxification treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal symptoms at day 3: clonidine versus clonidine plus amantadine, inpatient setting </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean withdrawal symptoms at day 3: clonidine versus clonidine plus amantadine was 9.83 days. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.56 days lower<br/> (5.97 lower to 1.15 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal symptoms at day 3: clonidine versus buprenorphine,inpatient setting</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean withdrawal symptoms at day 3: clonidine versus buprenorphine in inpatient setting was 12.5 days. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.4 days lower<br/> (2.93 lower to 0.13 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal symptoms at day 3: methadone versus tramadol</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean withdrawal symptoms at day 3: methadone versus tramadol was 8.5 days.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.04 days higher<br/> (2.68 lower to 2.76 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72<br/> (1 CCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal symptoms at day 3: methadone versus methadone plus gabapentin</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean withdrawal symptoms at day 3: methadone versus methadone plus gabapentin was 13.4 days. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.2 days lower<br/> (6.72 lower to 2.32 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of bias: high risk of performance and detection bias; unclear risk of selection bias.<br/> <sup>2</sup>Downgraded two levels for imprecision: one study with very few participants.<br/> <sup>3</sup>Downgraded one level for risk of bias: high risk of reporting bias; unclear risk of selection bias.<br/> <sup>4</sup>Downgraded one level for risk of bias: high risk of reporting bias; unclear risk of selection and attrition bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Pharmacological detoxification treatment compared to other pharmacological detoxification treatment for management of opium withdrawal</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/full#CD007522-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007522-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Pharmacological detoxification treatment versus other pharmacological detoxification treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Completion of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Baclofen versus clonidine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.63, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Clonidine versus clonidine plus amantadine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.86, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Clonidine versus buprenorphine, inpatient setting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.90, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Clonidine versus methadone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.01 [1.69, 2.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Methadone versus tramadol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.65, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Methadone versus methadone plus gabapentin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.96, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Tincture of opium versus methadone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.95, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Withdrawal symptoms at day 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Clonidine versus clonidine plus amantadine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.56 [‐5.97, ‐1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Clonidine versus buprenorphine, inpatient setting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐2.93, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Methadone versus tramadol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐2.68, 2.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Methadone versus methadone plus gabapentin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.20 [‐6.72, 2.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Pharmacological detoxification treatment versus other pharmacological detoxification treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007522.pub2/references#CD007522-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007522.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007522-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007522-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007522-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD007522-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD007522-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD007522-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007522-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007522\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007522\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007522\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007522\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007522\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007522.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007522.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007522.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007522.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007522.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714830654"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007522.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714830658"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007522.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d78437e92937d',t:'MTc0MDcxNDgzMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 